secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0001493152-23-039183
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric stockholders approve amended 2020 LTIP and share issuance to Lincoln Park Capital
--------------------------------------------------------------------------------

- Stockholders approved amendment to 2020 LTIP, increasing authorized shares by 38,259 to 350,000.
- Amendments remove evergreen auto-increase provision and add one-year minimum vesting.
- Issuance of common stock to Lincoln Park Capital Fund approved under Nasdaq Listing Rules 5635(a), (b), (d).
- All five director nominees elected; say-on-pay and ratification of Marcum LLP as auditor passed.
- Annual meeting turnout: 1,074,661 shares (49.3% of outstanding) constituted quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315223039183/0001493152-23-039183-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315223039183/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-039183

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer